Research Programs
This section offers an annual report of research programs and program leadership as reported by NCI-Designated Cancer Centers in the most recent full calendar year.
Instituation Name | Research Program Name | Leader's Full Name |
---|---|---|
Dana-Farber Cancer Institute | Breast Cancer Program | Leif Ellisen, MD, PhD; Elizabeth Mittendorf, MD, PhD; Sara Tolaney, MD, MPH |
Dana-Farber Cancer Institute | Cancer Care Delivery Research Program | Nancy Keating, MD, MPH; Jennifer Temel, MD; Jennifer Mack, MD, MPH |
Dana-Farber Cancer Institute | Cancer Cell Biology Program | Jeffrey Harper, PhD; Kornelia Polyak, MD, PhD; Raul Mostoslavsky, MD, PhD |
Dana-Farber Cancer Institute | Cancer Data Sciences Program | Martin Aryee, PhD; Xihong Lin, PhD; Franziska Michor, PhD |
Dana-Farber Cancer Institute | Cancer Epidemiology Program | Andrew Chan, MD, MPH; Brittany Charlton, ScD, MSc; Heather Eliassen, ScD |
Dana-Farber Cancer Institute | Cancer Genetics and Epigenetics Program | Gad Getz, MSc, PhD; Cigall Kadoch, PhD; Eliezer Van Allen, MD |
Dana-Farber Cancer Institute | Cancer Immunology Program | Arlene Sharpe, MD, PhD; Kai Wucherpfennig, MD, PhD |
Dana-Farber Cancer Institute | Cancer Risk, Prevention and Early Detection Program | Lecia Sequist, MD, MPH; Sapna Syngal, MD, MPH; Guillermo Tearney, MD, PhD |
Dana-Farber Cancer Institute | Developmental Therapeutics Program | Keith Flaherty, MD; Geoffrey Shapiro, MD, PhD |
Dana-Farber Cancer Institute | Gastrointestinal Malignancies Program | Ryan Corcoran, MD, PhD; Brian Wolpin, MD, PhD |
Dana-Farber Cancer Institute | Gynecologic Cancers Program | Cesar Castro, MD, MMsc; Alan D'Andrea, MD; Ursula Matulonis, MD |
Dana-Farber Cancer Institute | Kidney Cancer Program | David McDermott, MD; Toni Choueiri, MD; Sabina Signoretti, MD |
Dana-Farber Cancer Institute | Leukemia Program | Timothy Graubert, MD; Andrew Lane, MD, PhD; Jacalyn Rosenblatt, MD |
Dana-Farber Cancer Institute | Lung Cancer Program | Justin Gainor, MD; Bruce Johnson, MD; Carla Kim, PhD |
Dana-Farber Cancer Institute | Lymphoma and Myeloma Program | Matthew Davids, MD, MMsc; Irene Ghobrial, MD |
Dana-Farber Cancer Institute | Melanoma Program | David Fisher, MD, PhD; Frank Hodi, MD |
Dana-Farber Cancer Institute | Neuro-Oncology Program | Tracy Batchelor, MD, MPH; Daphne Haas-Kogan, MD; Scott Plotkin, MD, PhD; Mario Suva, MD, PhD |
Dana-Farber Cancer Institute | Prostate Cancer Program | Steven Balk, MD, PhD; Matthew Smith, MD, PhD; Mary-Ellen Taplin, MD |
Fox Chase Cancer Center | Cancer Prevention and Control | Margie Clapper, PhD; Michael Hall, MD |
Fox Chase Cancer Center | Cancer Signaling and Microenvironment | Edna Cukierman, PhD; John Karanicolas, PhD |
Fox Chase Cancer Center | Nuclear Dynamics and Cancer | Tomasz Skorski, MD, PhD; Johnathan Whetstine, PhD |
Johns Hopkins University | Cancer Chemical and Structural Biology | James Berger, PhD; Marikki Laiho, MD, PhD; Jun Liu, PhD |
Johns Hopkins University | Cancer Genetics and Epigenetics | Nilofer Azad, MD; Victor Velculescu, MD, PhD; Stephen Baylin, MD |
Johns Hopkins University | Cancer Immunology | Erika Pearce, PhD; Julie Brahmer, MD; Drew Pardoll, MD, PhD |
Johns Hopkins University | Cancer Invasion and Metastasis | Andrew Ewald, PhD; Ashani Weeraratna, PhD; Laura Wood, MD, PhD |
Johns Hopkins University | Cancer Molecular and Functional Imaging | Zaver Bhujwalla, MSc, PhD; Martin Pomper, MD, PhD |
Johns Hopkins University | Cancer Prevention and Control | Richard Roden, PhD; Alison Klein, MHS, PhD; Elizabeth Platz, ScD, MPH |
Johns Hopkins University | Hematologic Malignancies and BMT | Richard Ambinder, MD, PhD; Richard Jones, MD |
Memorial Sloan Kettering Cancer Center | Cancer Biology and Experimental Pathology | Scott Lowe, PhD; Charles Sawyers, MD |
Memorial Sloan Kettering Cancer Center | Clinical Research | Julio Garcia-Aguilar, MD, PhD; Carol Aghajanian, MD; Alexander Drilon, MD |
Memorial Sloan Kettering Cancer Center | Developmental and Stem Cell Biology | Katerina Hadjantonakis, PhD; Lorenz Studer, PhD |
Memorial Sloan Kettering Cancer Center | Experimental Therapeutics | Omar Abdel-Wahab, MD; Pito Lito, MD, PhD |
Memorial Sloan Kettering Cancer Center | Genomic Integrity | John Petrini, PhD; Agnel Sfeir, PhD |
Memorial Sloan Kettering Cancer Center | Imaging and Radiation Sciences | Simon Powell, MBBS, PhD; Jason Lewis, PhD |
Memorial Sloan Kettering Cancer Center | Immunology and Transplantation | Alexander Rudensky, PhD; Katherine Hsu, MD, PhD |
Memorial Sloan Kettering Cancer Center | Population Sciences Research Program | Jonine Bernstein, PhD; Kenneth Offit , MD; Jamie Ostroff, PhD |
Memorial Sloan Kettering Cancer Center | Regulation of Cell Behavior | Tobias Walther, PhD; Lydia Finley, PhD |
Memorial Sloan Kettering Cancer Center | Structural and Chemical Biology | Christopher Lima, PhD; Arvin Dar, PhD |
The Wistar Institute | Gene Expression and Regulation | Paul Lieberman, PhD; Bin Tian, PhD |
The Wistar Institute | Immunology, Microenvironment and Metastasis | Rugang Zhang, PhD |
The Wistar Institute | Molecular and Cellular Oncogenesis | Maureen Murphy, PhD; David Speicher, PhD |
Wake Forest School of Medicine | Cancer Genetics and Metabolism | Cristina Furdui, PhD; Timothy Pardee, MD, PhD |
Wake Forest School of Medicine | Cancer Prevention and Control | Eric Donny, PhD; John Salsman, PhD |
Wake Forest School of Medicine | Neuro-Oncology | Waldemar Debinski, MD, PhD; Glenn Lesser, MD |
Wake Forest School of Medicine | Signaling and Biotechnology | Karen Haas, PhD; Chang Lu, PhD |
The University of Alabama at Birmingham | Cancer Biology and Immunology | Troy Randall, PhD; Sunil Sudarshan, MD |
The University of Alabama at Birmingham | Cancer Control and Population Sciences | Elizabeth Brown, PhD, MPH; Laura Rogers, MD |
The University of Alabama at Birmingham | Experimental Therapeutics | Eddy Yang, MD, PhD; Narendra Wajapeyee, PhD; Suzanne Lapi, PhD |
The University of Alabama at Birmingham | Neuro-Oncology | Louis Nabors, MD; Anita Hjelmeland, PhD |
Albert Einstein College of Medicine | Cancer Epidemiology, Prevention and Control | H.Dean Hosgood, PhD; Bruce Rapkin, PhD |
Albert Einstein College of Medicine | Cancer Therapeutics | Stephen Almo, PhD; Evris Gavanthiotis, PhD; Yvonne Saenger, MD |
Albert Einstein College of Medicine | Stem Cell and Cancer Biology | Kira Gritsman, MD, PhD; Britta Will, PhD |
Albert Einstein College of Medicine | Tumor Microenvironment and Metastises | Julio Aguirre-Ghiso, PhD; Maja Oktay, MD, PhD |
College of Physicians & Surgeons Columbia University | Cancer Genomics and Epigenomics | Jean Gautier, PhD; Raul Rabadan, PhD; Susan Bates, MD |
College of Physicians & Surgeons Columbia University | Cancer Population Science | Dawn Hershman, MD, MS; Mary Beth Terry, PhD; Chin Hur, MD, MPH |
College of Physicians & Surgeons Columbia University | Precision Oncology and Systems Biology | Andrea Califano, Dr; Kenneth Olive, PhD; Gulam Manji, MD, PhD |
College of Physicians & Surgeons Columbia University | Tumor Biology and Microenvironment | Michael Shen, PhD; Timothy Wang, MD; Barbara Pro, MD |
Massachusetts Institute of Technology | Cancer Biology and Immunology | Karl Wittrup, PhD; Stefani Spranger, PhD |
Massachusetts Institute of Technology | Genetic and Cellular Programs in Cancer | John Love, PhD; Eliezer Calo, PhD |
Massachusetts Institute of Technology | Systems and Engineering Approaches to Cancer | Michael Yaffe, MD, PhD; Scott Manalis, PhD |
University of Southern California | Cancer Control Research | Myles Cockburn, PhD; Jennifer Unger, PhD |
University of Southern California | Cancer Epidemiology | Christopher Haiman, ScD; Veronica Setiawan, PhD |
University of Southern California | Epigenetic Regulation in Cancer | Yali Dou, PhD; Bodour Salhia, PhD |
University of Southern California | Translational and Clinical Sciences | Heinz-Josef Lenz, MD; Fumito Ito, MD, PhD |
University of Southern California | Tumor Immunotherapy and Microenvironment | W.Martin Kast, PhD |
Salk Institute | Genome Stability, Epigenetics and Aging in Cancer | Jan Karlseder, PhD; Diana Hargreaves, PhD |
Salk Institute | Tumor Immunology, Metabolism and Therapeutics | Christian Metallo, PhD; Janelle Ayres, PhD |
Duke University Medical Center | Cancer Biology | Jen-Tsan Chi, MD, PhD; Micah Luftig, PhD; Ann Pendergast, PhD |
Duke University Medical Center | Cancer Prevention and Control | Leah Zullig, PhD; Kathryn Pollak, PhD |
Duke University Medical Center | Cancer Risk, Detection and Interception | Meira Epplein, MA, MS, PhD; Katherine Garman, MD |
Duke University Medical Center | Immuno-Oncology | Stefanie Sarantopoulos, MD, PhD; Scott Antonia, MD, PhD |
Duke University Medical Center | Neuro-Oncology | Gerald Grant, MD; Kyle Walsh, PhD |
Duke University Medical Center | Precision Cancer Medicine and Investigational Therapeutics | Shannon McCall, BS, MD; Dorothy Sipkins, MD, PhD; John Strickler, MD |
Duke University Medical Center | Radiation Oncology and Imaging | Manisha Palta, MD; Nimmi Ramanujam, BS, MS, PhD; Chuan-Yuan Li, BS, DSc |
University of Wisconsin Carbone Cancer Center | Cancer Genetic and Epigenetic Mechanisms | Wei Xu, PhD; Emery Bresnick, PhD |
University of Wisconsin Carbone Cancer Center | Cancer Prevention and Control | Nihal Ahmad, PhD |
University of Wisconsin Carbone Cancer Center | Developmental Therapeutics | Christian Capitini, MD; Dustin Deming, MD; Beth Weaver, PhD |
University of Wisconsin Carbone Cancer Center | Human Cancer Virology | Shannon Kenney, MD; Robert Kalejta, PhD |
University of Wisconsin Carbone Cancer Center | Imaging and Radiation Sciences | Robert Jeraj, PhD; Randall Kimple, MD, PhD; Pallavi Tiwari, PhD |
University of Wisconsin Carbone Cancer Center | Tumor Microenvironment | Pamela Kreeger, PhD; Joshua Lang, MD, MS |
University of Chicago Comprehensive Cancer Center | Cancer Prevention and Control | Brandon Pierce, PhD; Tara Henderson, MD, MPH; Loren Saulsberry, PhD |
University of Chicago Comprehensive Cancer Center | Clinical and Experimental Therapeutics | Russell Szmulewitz, MD; Chin-Tu Chen, PhD; Wendy Stock, MD; Jennifer McNeer, MD |
University of Chicago Comprehensive Cancer Center | Immunology and Cancer | Thomas Gajewski, MD, PhD; Peter Savage, PhD; Justin Kline, MD |
University of Chicago Comprehensive Cancer Center | Molecular Mechanisms of Cancer | Kay Macleod, PhD; Barbara Kee, PhD; Megan McNerney, MD, PhD |
Mayo Clinic | Cancer Immunology and Immunotherapy | Haidong Dong, MD, PhD; Keith Knutson, PhD; Virginia Shapiro, PhD |
Mayo Clinic | Cell Biology | Panagiotis Anastasiadis, PhD; Mark McNiven, PhD |
Mayo Clinic | Experimental Therapeutics | Scott Kaufmann, MD, PhD; Zhenkun Lou, PhD |
Mayo Clinic | Gastrointestinal Cancer | Tanios Bekaii-Saab, MD; Martin Fernandez-Zapico, MD |
Mayo Clinic | Gene and Virus Therapy | Mitesh Borad, MD; Richard Vile, PhD |
Mayo Clinic | Hematologic Malignancies | Stephen Ansell, MD, PhD; Leif Bergsagel, MD; Asher Chanan-Khan, MD |
Mayo Clinic | Neuro-oncology | Steven Rosenfeld, MD, PhD; Jann Sarkaria, MD; Nhan Tran, PhD |
Mayo Clinic | Population Sciences | James Cerhan, MD, PhD; Kathryn Ruddy, MD; Mark Sherman, MD; Ping Yang, MD, PhD |
Mayo Clinic | Women's Cancer | Jamie Bakkum-Gamez, MD; Amy Degnim, MD; Matthew Goetz, MD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Biostatistics and Computational Biology | Charles Kooperberg, PhD; Philip Bradley, PhD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Breast and Ovary Cancers | Elizabeth Swisher, MD; Cyrus Ghajar, MD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Cancer Basic Biology | Jonathan Cooper, PhD; Jay Shendure, MD, PhD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Cancer Epidemiology, Prevention and Control | Marian Neuhouser, PhD, RD; Eric Chow, MD, MPH |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Cancer Immunology | Marie Bleakley, MD, PhD; Evan Newell, PhD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Hematologic Malignancies | Frederick Appelbaum, MD; Effie Petersdorf, MD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Pathogen Associated Malignancies | Denise Galloway, PhD; Paul Nghiem, MD, PhD |
Fred Hutch / University of Washington / Seattle Children’s Cancer Consortium | Prostate Cancer | Peter Nelson, MD; Dan Lin, MD |
University of California at Los Angeles | Cancer and Stem Cell Biology | Gay Crooks, MBBS; Brigitte Gomperts, MD |
University of California at Los Angeles | Cancer Control and Survivorship | Patricia Ganz, MD; Roshan Bastani, PhD; Beth Glenn, PhD |
University of California at Los Angeles | Cancer Molecular Imaging, Nanotechnology and Theranostics | Johannes Czernin, MD; Caius Radu, MD; Jeffrey Zink, PhD |
University of California at Los Angeles | Epigenomics, RNA and Gene Regulation | Michael Carey, PhD; Siavash Kurdistani, MD, PhD |
University of California at Los Angeles | Signal Transduction and Therapeutics | Richard Finn, MD; Edward Garon, MD |
University of California at Los Angeles | Tumor Immunology | Antoni Ribas, MD, PhD; Yvonne Chen, PhD |
Roswell Park Comprehensive Cancer Center | Cancer Stress Biology | Elizabeth Repasky, PhD; Anurag Singh, MD |
Roswell Park Comprehensive Cancer Center | Developmental Therapeutics | Dean Tang, PhD; Igor Puzanov, MD |
Roswell Park Comprehensive Cancer Center | Population Sciences | Christine Ambrosone, PhD; Andrew Hyland, PhD |
Roswell Park Comprehensive Cancer Center | Tumor Immunology and Immunotherapy | Scott Abrams, PhD; Emese Zsiros, MD, PhD |
The Ohio State University | Cancer Biology | Matthew Ringel, MD; Philip Tsichlis, MD |
The Ohio State University | Cancer Control | Electra Paskett, PhD; Theodore Wagener, PhD; Diane Von Ah, PhD |
The Ohio State University | Leukemia Research | Woyach Jennifer, MD; Rose Lapalombella, PhD |
The Ohio State University | Molecular Carcinogenesis and Chemoprevention | Steven Clinton, MD, PhD; Richard Fishel, PhD |
The Ohio State University | Translational Therapeutics | David Carbone, MD, PhD; Blake Peterson, PhD; Elaine Mardis, PhD |
Virginia Commonwealth University | Cancer Biology | Azeddine Atfi, PhD; Paula Bos, PhD |
Virginia Commonwealth University | Cancer Prevention and Control | Victoria Findlay, PhD; Oxana Palesh, PhD, MPH |
Virginia Commonwealth University | Developmental Therapeutics | Steven Grant, MD; Anthony Faber, PhD; Xiang-Yang Wang, PhD |
University of North Carolina Chapel Hill | Breast Cancer Research | Gaorav Gupta, MD, PhD; Charles Perou, PhD |
University of North Carolina Chapel Hill | Cancer Cell Biology | James Bear, PhD |
University of North Carolina Chapel Hill | Cancer Epidemiology | Louise Henderson, PhD, MSPH; Melissa Troester, PhD, MPH, MS; Hazel Nichols, PhD, MSc |
University of North Carolina Chapel Hill | Cancer Genetics | Ian Davis, MD, PhD; William Kim, MD; Terry Magnuson, PhD |
University of North Carolina Chapel Hill | Cancer Prevention and Control | Ethan Basch, MD, MSc; Kurt Ribisl, PhD |
University of North Carolina Chapel Hill | CCSG Admin Core | Henry Earp, MD; David Darr, MBA, MSc |
University of North Carolina Chapel Hill | Clinical Research | Elizabeth Dees, MD, MSc; Matthew Milowsky, MD; Jen Jen Yeh, MD |
University of North Carolina Chapel Hill | Immunology | Gianpietro Dotti, MD; Yuliya Pylayeva-Gupta, PhD |
University of North Carolina Chapel Hill | Molecular Therapeutics | Chad Pecot, MD; Gary Johnson, PhD |
University of North Carolina Chapel Hill | Virology | Blossom Damania, PhD; Dirk Dittmer, PhD |
New York University Langone Health | Cancer Cell Biology | Richard Possemato, PhD; Alec Kimmelman, MD, PhD |
New York University Langone Health | Cancer Genome Dynamics | Hannah Klein, PhD; William Carroll, MD |
New York University Langone Health | Epidemiology and Cancer Control | Jiyoung Ahn, PhD; Danil Makarov, MD |
New York University Langone Health | Melanoma | Jeffrey Weber, MD, PhD; Iman Osman, MD |
New York University Langone Health | Tumor Immunlogy | Kwok-Kin Wong, MD, PhD; Michelle Krogsgaard, PhD |
Yale University School of Medicine | Cancer Immunology | Marcus Bosenberg, MD, PhD; Mario Sznol, MD; Carla Rothlin, PhD |
Yale University School of Medicine | Cancer Prevention and Control | Xiaomei Ma, PhD; Michaela Dinan, PhD |
Yale University School of Medicine | Cancer Signaling Networks | Katerina Politi, PhD; Don Nguyen, PhD; Isaac Kim, MD, PhD, MBA |
Yale University School of Medicine | Developmental Therapeutics | Karen Anderson, PhD; Barbara Burtness, MD, PhD |
Yale University School of Medicine | Genomics, Genetics and Epigenetics | Lajos Pusztai, MD, DPhil; Jeffrey Townsend, PhD; Qin Yan, PhD |
Yale University School of Medicine | Radiobiology and Genome Integrity | Joseph Contessa, MD, PhD; Megan King, PhD |
University of Pennsylvania | Breast Cancer | Angela DeMichele, MD; Roger Greenberg, MD, PhD |
University of Pennsylvania | Cancer Control | Karen Ganz, PhD, MPH; Steven Joffe, MD, MPH |
University of Pennsylvania | Cancer Therapeutics | Naomi Haas, MD; Kim Reiss, MD |
University of Pennsylvania | Hematologic Malignancies | Nancy Speck, PhD; Edward Stadtmauer, MD |
University of Pennsylvania | Immunobiology | Warren Pear, MD, PhD; E. Wherry, PhD |
University of Pennsylvania | Pediatric Oncology | Stephan Grupp, MD, PhD; Kai Tan, PhD |
University of Pennsylvania | Radiobiology and Imaging | Theresa Busch, PhD; Daniel Pryma, MD |
University of Pennsylvania | Tobacco and Environmental Carcinogenesis | Trevor Penning, PhD; Andrew Strasser, PhD |
University of Pennsylvania | Tumor Biology | Shelley Berger, PhD; Matthew Weitzman, PhD |
University of Texas | Breast Cancer | Wendy Woodward, MD, PhD; Debasish Tripathy, MD |
University of Texas | Cancer Biology and Metastasis | Dihua Yu, PhD; Raghu Kalluri, MD, PhD |
University of Texas | Cancer Genetics and Epigenetics | Xiaodong Cheng, PhD; Guillermina Lozano, PhD |
University of Texas | Cancer Neuroscience | Vinay Puduvalli, MD; Juan Fueyo-Margareto, MD; Frederick Lang, Jr, MD |
University of Texas | Cancer Prevention | Powel Brown, MD, PhD; Paul Cinciripini, PhD; Karen Basen-Engquist, PhD, MPH |
University of Texas | Developmental Therapeutics | Funda Meric-Bernstam, MD; Rugang Zhang, PhD; Philip Jones, PhD |
University of Texas | Gastrointestinal Cancers | Scott Kopetz, MD, PhD; Yi-Qian Nancy You, MD; Anirban Maitra, MBBS |
University of Texas | Gynecological Cancers | Karen Lu, MD; Anil Sood, MD; Amir Jazaeri, MD |
University of Texas | Head and Neck Cancer | Jeffrey Myers, MD; Maura Gillison, MD, PhD; Steven Sherman, MD |
University of Texas | Hematological Malignancies | Robert Orlowski, MD, PhD; Michael Andreeff, MD, PhD |
University of Texas | Imaging-Driven Biology and Therapy Program | Kristy Brock, PhD; Clifton Fuller, MD, PhD |
University of Texas | Immunology | James Allison, PhD; Jeffrey Molldrem, MD |
University of Texas | Lung Cancer | John Heymach, MD, PhD; Lauren Byers, MD; Steven Lin, MD, PhD |
University of Texas | Prostate Cancer | Christopher Logothetis, MD; Timothy Thompson, PhD |
University of Texas | Risk, Detection, and Outcomes | Paul Scheet, PhD; Sanjay Shete, PhD; Samir Hanash, MD, PhD; Sharon Giordano, MD, MPH |
University of Texas | Stem Cell Transplantation and Cellular Therapy | Elizabeth Shpall, MD; Richard Champlin, MD; Katy Rezvani, MD, PhD |
St. Jude Children's Research Hospital | Cancer Biology | Douglas Green, PhD; Richard Kriwacki, PhD |
St. Jude Children's Research Hospital | Cancer Control and Survivorship | Kirsten Ness, PT, PhD; Gregory Armstrong, MD |
St. Jude Children's Research Hospital | Developmental Biology and Solid Tumor | Michael Dyer, PhD; Alberto Pappo, MD |
St. Jude Children's Research Hospital | Hematological Malignancies | Charles Mullighan, MBBS, MD; Ching-Hon Pui, MD |
St. Jude Children's Research Hospital | Neurobiology and Brain Tumor | Suzanne Baker, PhD; Giles Robinson, MD |
Wayne State University School of Medicine | Molecular Imaging | Nerissa Viola, PhD; Anthony Shields, MD, PhD |
Wayne State University School of Medicine | Molecular Therapeutics | Asfar Azmi, PhD; Ammar Sukari, MD; Jeffrey Zonder, MD |
Wayne State University School of Medicine | Population Studies and Disparities Research | Jennifer Beebe-Dimmer, PhD, MPH; Lauren Hamel, PhD |
Wayne State University School of Medicine | Tumor Biology and Microenvironment | Kay-Uwe Wagner, PhD; Hasan Korkaya, DVM, PhD |
University of Arizona | Cancer Biology Program | Nathan Ellis, PhD; Koenraad VanDoorslaer, PhD |
University of Arizona | Cancer Prevention and Control Program | Jennifer Bea, PhD; Heidi Hamann, PhD |
University of Arizona | Clinical and Translational Oncology Program | Steffan Nawrocki, PhD; Aaron Scott, MD |
University of California, San Diego | Cancer Biology and Signaling | Kun-Liang Guan, PhD; Jing Yang, PhD |
University of California, San Diego | Cancer Control | Samir Gupta, MD; Noe Crespo, PhD |
University of California, San Diego | Hematologic Malignancies | Catriona Jamieson, MD, PhD; Thomas Kipps, MD, PhD |
University of California, San Diego | Solid Tumor Therapeutics | Ezra Cohen, MD; Judith Varner, PhD |
University of California, San Diego | Structural and Functional Genomics | Joseph Califano, MD; Jill Mesirov, PhD |
Dartmouth Health | Cancer Population Sciences | Brock Christensen, PhD |
Dartmouth Health | Cancer Signaling, Genomes, and Networks | Arminja Kettenbach, PhD; Konstantin Dragnev, MD; Todd Miller, PhD |
Dartmouth Health | Immunology and Cancer Immunotherapy | Mary Jo Turk, PhD; Kenneth Meehan, MD |
Dartmouth Health | Translational Engineering in Cancer | Keith Paulsen, PhD; Irene Georgakoudi, PhD, MSc, BA |
Purdue University Center for Cancer Research | Cell Identity and Signaling | Ourania Andrisani, PhD; Majid Kazemian, PhD |
Purdue University Center for Cancer Research | Drug Delivery and Molecular Sensing | Fang Huang, PhD; Yoon Yeo, PhD |
Purdue University Center for Cancer Research | Targets, Structures and Drugs | Deborah Knapp, DVM; Herman Sintim, PhD; John Tesmer, PhD |
Sanford Burnham Prebys Medical Discovery Institute | Aging, Cancer and Immuno-oncology | Linda Bradley, PhD |
Sanford Burnham Prebys Medical Discovery Institute | Cell and Molecular Biology of Cancer | Cosimo Commisso, PhD |
Sanford Burnham Prebys Medical Discovery Institute | Tumor Initiation and Maintenance | Peter Adams, PhD |
Beckman Research Institute | Cancer Control and Population Sciences | Susan Neuhausen, PhD; Saro Armenian, DO, MPH |
Beckman Research Institute | Cancer Immunotherapeutics | Peter Lee, MD; Hua Yu, PhD |
Beckman Research Institute | Developmental Cancer Therapeutics | Miguel Villalona-Calero, MD; Sunil Sharma, MD, FACP, MBA |
Beckman Research Institute | Hematologic Malignancies | Stephen Forman, MD; Guido Marcucci, MD |
Beckman Research Institute | Molecular and Cellular Biology of Cancer | Binghui Shen, PhD; Charles Brenner, PhD |
The Jackson Laboratory Cancer Center | Genetic Models for Precision Cancer Medicine | Jeffery Chuang, PhD; Olga Anczukow, PhD |
University of Nebraska Medical Center | Cancer Biology Program | Hamid Band, MD, PhD |
University of Nebraska Medical Center | Gastrointestinal Cancer Program | Jennifer Black, PhD; Chi Lin, MD, PhD |
University of Nebraska Medical Center | Targets, Modulators and Delivery Program | Robert Lewis, PhD; Amarnath Natarajan, PhD; Sarah Holstein, MD, PhD |
University of Utah | Cancer Control and Population Sciences | Jennifer Doherty, MS, PhD; Kathleen Mooney, PhD, RN, FAAN |
University of Utah | Cell Response and Regulation | Shannon Buckley, PhD; Sheri Holmen, PhD |
University of Utah | Experimental Therapeutics | Howard Colman, MD, PhD; Martin McMahon, PhD |
University of Utah | Nuclear Control of Cell Growth and Differentiation | Jason Gertz, PhD; Jared Rutter, PhD |
Case Western Reserve University | Cancer Genomics and Epigenomics | ZhengheJohn Wang, PhD |
Case Western Reserve University | Cancer Imaging | James Basilion, PhD; Zhenghong Lee, PhD; Agata Exner, PhD |
Case Western Reserve University | Developmental Therapeutics | John Letterio, MD; Jennifer Yu, MD, PhD; Jordan Winter, MD |
Case Western Reserve University | Immune Oncology | Alex Huang, MD, PhD; Timothy Chan, MD, PhD; David Wald, MD, PhD |
Case Western Reserve University | Molecular Oncology | Justin Lathia, PhD; Quintin Pan, PhD |
Case Western Reserve University | Population and Cancer Prevention | Gregory Cooper, MD; Fredrick Schumacher, PhD, MPH; Adam Burgener, PhD |
University of Virginia | Cancer Biology | John Bushweller, PhD; Daniel Gioeli, PhD |
University of Virginia | Cancer Control and Population Health | Li Li, MD, PhD; Jamie Zoellner, RD, PhD; Kelly Shaffer, PhD |
University of Virginia | Cancer Therapeutics | Kimberly Kelly, PhD; Benjamin Purow, MD; Richard Price, PhD |
University of Virginia | Molecular Genetics and Epigenetics | P Todd Stukenberg, PhD; Hui Li, PhD |
Cold Spring Harbor Laboratory Cancer Center | Cancer Genetics and Genomics | Tobias Janowitz, MD, PhD; Adam Siepel, PhD |
Cold Spring Harbor Laboratory Cancer Center | Cellular Communication in Cancer | Linda Van Aelst, PhD; Corina Amor Vegas, MD, PhD |
Cold Spring Harbor Laboratory Cancer Center | Gene Regulation and Inheritance | Adrian Krainer, PhD; Justin Kinney, PhD |
University of Michigan Rogel Cancer Center | Cancer Control and Population Sciences | Celeste Pearce, PhD; Sarah Hawley, PhD, MPH; Lauren Wallner, PhD, MPH |
University of Michigan Rogel Cancer Center | Cancer Genetics | Kathleen Cho, MD; Sami Malek, MD |
University of Michigan Rogel Cancer Center | Cancer Hematopoiesis and Immunology | Weiping Zou, MD, PhD; Ryan Wilcox, MD, PhD |
University of Michigan Rogel Cancer Center | Developmental Therapeutics | Jolanta Grembecka, PhD; Judith Leopold, PhD |
University of Michigan Rogel Cancer Center | Signaling and Tumor Microenvironment | Marina Pasca di Magliano, PhD; Yatrik Shah, PhD |
University of Michigan Rogel Cancer Center | Translational and Clinical Research | Theodore Lawrence, MD, PhD; Joshi Alumkal, MD; Ulka Vaishampayan, MBBS |
University of Colorado Cancer Center | Cancer Prevention and Control | Jamie Studts, PhD; Stacy Fischer, MD |
University of Colorado Cancer Center | Developmental Therapeutics | Antonio Jimeno, MD, PhD; Daniel Gustafson, PhD; Lia Gore, MD |
University of Colorado Cancer Center | Molecular and Cellular Oncology | Patricia Ernst, PhD; Tin Tin Su, PhD |
University of Colorado Cancer Center | Tumor-Host Interactions | Diana Cittelly, PhD; Jill Slansky, PhD; Michael Verneris, MD |
UPMC Hillman Cancer Center | Biobehavioral Cancer Control | Catherine Bender, PhD, RN, FAAN; Dana Bovbjerg, PhD |
UPMC Hillman Cancer Center | Cancer Biology | Steffi Oesterreich, PhD; Ronald Buckanovich, MD, PhD |
UPMC Hillman Cancer Center | Cancer Epidemiology and Prevention | Jian-Min Yuan, MD, PhD; James Herman, MD |
UPMC Hillman Cancer Center | Cancer Immunology and Immunotherapy | Dario Vignali, PhD; Hassane Zarour, MD |
UPMC Hillman Cancer Center | Cancer Therapeutics | Peter Wipf, PhD; Adam Brufsky, MD, PhD |
UPMC Hillman Cancer Center | Cancer Virology | Haitao Guo, PhD; Shou-Jiang Gao, PhD |
UPMC Hillman Cancer Center | Genome Stability | Patricia Opresko, PhD; Bennett Van Houten, PhD |
Georgetown University Medical Center | Cancer Cell Biology | Gary Kupfer , MD; David Robbins, PhD; Benjamin Tycko, MD, PhD |
Georgetown University Medical Center | Cancer Host Interactions | Joyce Slingerland `, MD, PhD; Yi Zhang, MD, PhD |
Georgetown University Medical Center | Cancer Prevention and Control | Kenneth Tercyak, PhD; Lisa Carter-Bawa, PhD, APRN, ANP-C; Laura Rozek, PhD |
University of Texas Health Science Center at San Antonio | Cancer Development and Progression | Patrick Sung, DPhil; Ratna Vadlamudi, PhD |
University of Texas Health Science Center at San Antonio | Experimental and Developmental Therapeutics | Andrew Brenner, MD, PhD; Manjeet Rao, PhD |
University of Texas Health Science Center at San Antonio | Population Science and Prevention | Gail Tomlinson, MD, PhD; Addanki Kumar, PhD |
Northwestern University | Cancer and Physical Sciences (CAPS) | Vadim Backman, PhD; Gayle Woloschak, PhD |
Northwestern University | Cancer Control and Survivorship (CCS) | Christine Rini, PhD; Betina Yanez, PhD |
Northwestern University | Cancer Epigenetics and Nuclear Dynamics (CEND) | Ali Shilatifard, PhD; Sadie Wignall, PhD; Feng Yue, PhD |
Northwestern University | Cancer Prevention (CP) | Seema Khan, MD; Bonnie Spring, PhD; Brian Hitsman, PhD |
Northwestern University | Hematologic Malignancies (HM) | Elizabeth Eklund, MD; Leo Gordon, MD; Yan Liu, PhD |
Northwestern University | Membranes, Organelles and Metabolism (MOM) | Navdeep Chandel, PhD; Curt Horvath, PhD |
Northwestern University | Translational Research in Solid Tumors (TRIST) | Marcus Peter, PhD; Daniela Matei, MD; Jeffrey Sosman, MD |
Northwestern University | Tumor Environment and Metastasis (TEAM) | Hidayatullah Munshi, MD; Luisa Iruela-Arispe, PhD; Bin Zhang, MD, PhD |
University of California, Irvine | Biotechnology, Imaging and Drug Development | Anand Ganesan, MD, PhD; Gregory Weiss, PhD; Thomas Milner, PhD |
University of California, Irvine | Cancer Control | Sunmin Lee, ScD, MPH; Joel Milam, PhD |
University of California, Irvine | Systems, Pathways and Targets | John Lowengrub, PhD; Angela Fleischman, MD, PhD |
Vanderbilt University | Breast Cancer | Justin Balko, PharmD, PhD; Vandana Abramson, MD |
Vanderbilt University | Cancer Cell Biology | Jin Chen, MD, PhD |
Vanderbilt University | Cancer Epidemiology | Xiao-Ou Shu, MD, MPH, PhD; Martha Shrubsole, PhD |
Vanderbilt University | Cancer Health Outcomes and Control | Daniel Barocas, MD, MPH; Stacie Dusetzina, PhD; Eric Grogan, MD, MPH |
Vanderbilt University | Gastrointestinal Cancer | Cathy Eng, MD |
Vanderbilt University | Genome Maintenance | David Cortez, PhD; William Tansey, PhD |
Vanderbilt University | Host-Tumor Interactions | Jeffrey Rathmell, PhD; John Wilson, PhD |
Vanderbilt University | Translational Research and Interventional Oncology | Douglas Johnson, MD, MSCI; Kristen Ciombor, MD, MSCI; Eben Rosenthal, MD |
Oregon Health & Science University | Cancer Biology | Melissa Wong, PhD; Teresa Zimmers, PhD |
Oregon Health & Science University | Cancer Prevention and Control | Sue Flocke, PhD |
Oregon Health & Science University | Quantitative Oncology | Laura Heiser, PhD; Young Chang, PhD, MS, BS |
Oregon Health & Science University | Translational Oncology | Jeffrey Tyner, PhD; Lara Davis, MD |
Univeristy of Hawaiʻi | Cancer Biology | Xin Chen, PhD |
Univeristy of Hawaiʻi | Population Sciences in the Pacific | Sungshim Park, PhD; Pallav Pokhrel, PhD |
Rutgers Biomedical and Health Sciences | Cancer Metabolism and Immunology | Christian Hinrichs, MD; Wei-Xing Zong, PhD |
Rutgers Biomedical and Health Sciences | Cancer Pharmacology | X.F.Steven Zheng, PhD; Stephen Burley, MD, DPhil |
Rutgers Biomedical and Health Sciences | Cancer Prevention and Control | Carolyn Heckman, PhD; Elisa Bandera, MD, PhD |
Rutgers Biomedical and Health Sciences | Clinical Investigations and Precision Therapeutics | Wadih Arap, MD, PhD; Shridar Ganesan, MD, PhD |
Rutgers Biomedical and Health Sciences | Genomic Instability and Cancer Genetics | Cristina Montagna, PhD; Chang Chan, PhD |
Moffitt Cancer Center | Cancer Biology and Evolution | Joseph Kissil, PhD |
Moffitt Cancer Center | Cancer Epidemiology | Peter Kanetsky, PhD, MPH; Matthew Schabath, PhD |
Moffitt Cancer Center | Health Outcomes and Behavior | Healther Jim, PhD; Tiffany Carson, PhD, MPH |
Moffitt Cancer Center | Immuno-Oncology | Frederick Locke, MD; Paulo Rodriguez, PhD |
Moffitt Cancer Center | Molecular Medicine | Jhanelle Gray, MD; Derek Duckett, PhD |
University of Minnesota | Carcinogenesis and Chemoprevention | Lisa Peterson, PhD; Frank Ondrey, MD, PhD |
University of Minnesota | Cellular Mechanisms | Daniel Harki, PhD; Kathryn Schwertfeger, PhD |
University of Minnesota | Genetic Mechanisms of Cancer | Masato Yamamoto, MD, PhD; Rong Huang, PhD |
University of Minnesota | Immunology | Yoji Shimizu, PhD; Jeffrey Miller, MD |
University of Minnesota | Screening, Prevention, Etiology, Cancer Survivorship | Heather Nelson, PhD; Anne Blaes, MD |
University of Minnesota | Transplant and Cellular Therapy | John Wagner, MD |
University of California, San Francisco | Breast Oncology | Laura van 't Veer, PhD; Laura Esserman, MD, MBA; Andrei Goga, MD, PhD |
University of California, San Francisco | Cancer Control | Tung Nguyen, MD; Pamela Ling, MD; Scarlett Gomez, PhD, MPH |
University of California, San Francisco | Cancer Immunology and Immunotherapy | Lewis Lanier, PhD; Lawrence Fong, MD; Thomas Martin, MD |
University of California, San Francisco | Molecular Oncology | Charles Craik, PhD; Pamela Munster, MD; Sourav Bandyopadhyay, PhD |
University of California, San Francisco | Neurologic Oncology | Susan Chang, MD; Nicholas Butowski, MD; Manish Aghi, MD, PhD |
University of California, San Francisco | Pediatric Malignancies | William Weiss, MD, PhD; Alejandro Sweet-Cordero, MD; Sabine Mueller, MD, PhD |
University of California, San Francisco | Prostate Cancer | Eric Small, MD; Felix Feng, MD; Matthew Cooperberg, MD |
Indiana University Melvin & Bren Simon Comprehensive Cancer Center | Cancer Prevention and Control | Todd Skaar, PhD; Rachel Katzenellenbogen, MD |
Indiana University Melvin & Bren Simon Comprehensive Cancer Center | Experimental and Developmental Therapeutics | Mateusz Opyrchal, MD, PhD; Karen Pollok, PhD |
Indiana University Melvin & Bren Simon Comprehensive Cancer Center | Hematopoiesis and Hematologic Malignancies | Reuben Kapur, PhD; Huda Salman, MD, PhD |
Indiana University Melvin & Bren Simon Comprehensive Cancer Center | Tumor Microenvironment and Metastasis | Kenneth Nephew, PhD; Melissa Fishel, PhD |
University of Iowa | CEPS Cancer Epidemiology and Population Science | Mary Charlton, PHD, BSN; MARK VANDER WEG, PHD |
University of Iowa | CGP Cancer Genes and Pathways | Rebecca Dodd, PHD; DAWN QUELLE, PHD |
University of Iowa | ET Experimental Therapeutics | Bryan Allen, MD, PHD; ALIASGER SALEM, PHD |
University of Iowa | FRMI Free Radical Metabolism and Imaging | Douglas Spitz, PHD; YUSUF MENDA, MD |
Washington University School of Medicine and Barnes-Jewish Hospital | Breast Cancer Research Program | Jason Weber, PhD; Katherine Weilbaecher, MD; Cynthia Ma, MD, PhD |
Washington University School of Medicine and Barnes-Jewish Hospital | Hematopoietic Development and Malignancy Program | Peter Westervelt, MD, PhD; Todd Fehniger, MD, PhD; Laura Schuettpelz, MD, PhD |
Washington University School of Medicine and Barnes-Jewish Hospital | Mechanisms of Cancer Biology Program | Sheila Stewart, PhD; Greg Longmore, MD; Roberta Faccio, PhD |
Washington University School of Medicine and Barnes-Jewish Hospital | Oncologic Imaging Program | Farrokh Dehdashti, MD; Daniel Thorek, PhD |
Washington University School of Medicine and Barnes-Jewish Hospital | Prevention and Control Program | Aimee James, PhD, MPH; Ross Brownson, PhD; Adetunji Toriola, MD, PhD |
Washington University School of Medicine and Barnes-Jewish Hospital | Solid Tumor Therapeutics Program | Joshua Rubin, MD, PhD; Ryan Fields, MD; Ramaswamy Govindan, MD |
Washington University School of Medicine and Barnes-Jewish Hospital | Tumor Immunology Program | Robert Schreiber, PhD; William Gillanders, MD; David DeNardo, PhD |
University of California, Davis | Biomedical Technology | Orin Bloch, MD; Laura Marcu, PhD |
University of California, Davis | Cancer Therapeutics | Kit Lam, MD, PhD; Richard Valicenti, MD |
University of California, Davis | Comparative Oncology | Michael Kent, DVM; Robert Canter, MD; Xinbin Chen, DVM, PhD |
University of California, Davis | Molecular Oncology | Kermit Carraway, PhD; Wolf-Dietrich Heyer, PhD |
University of California, Davis | Population Sciences and Health Disparities | Diana Miglioretti, PhD; Theresa Keegan, PhD |
University of New Mexico, Albuquerque | Cancer Control and Population Science | Shugang Leng, PhD; Cindy Blair, MPH, PhD |
University of New Mexico, Albuquerque | Cancer Therapeutics | Eric Prossnitz, PhD; Sarah Adams, MD |
University of New Mexico, Albuquerque | Cellular and Molecular Oncology | Michelle Ozbun, PhD; Steve Belinsky, PhD |
University of New Mexico, Albuquerque | Training | Jennifer Gillette, PhD |
Stanford University | Cancer Biology and Cancer Stem Cells | Laura Attardi, PhD; Roeland Nusse, PhD |
Stanford University | Cancer Imaging and Early Detection | Heike Daldrup-Link, MD, PhD; Daniel Rubin, MD, MS |
Stanford University | Cancer Immunotherapy | Crystal Mackall, MD; Edgar Engleman, MD |
Stanford University | Cancer Therapeutics | Nathanael Gray, PhD; James Ford, MD |
Stanford University | Hematologic Malignancies | Ronald Levy, MD; Ravindra Majeti, MD, PhD |
Stanford University | Population Sciences | Esther John, PhD, MSPH; Allison Kurian, MD, MSc; Marcia Stefanick, PhD |
Stanford University | Radiation Biology | Quynh-Thu Le, MD; Maximilian Diehn, MD, PhD |
Baylor College of Medicine | Breast Cancer Program | Jeffrey Rosen, PhD; Mothaffar Rimawi, MD |
Baylor College of Medicine | Cancer Cell and Gene Therapy | Helen Heslop, MD, DSc(Hon); Margaret Goodell, PhD |
Baylor College of Medicine | Cancer Prevention and Population Sciences | Hoda Badr, PhD; Philip Lupo, PhD |
Baylor College of Medicine | Cell Signaling and Metabolism | David Rowley, PhD; Arun Sreekumar, PhD |
Baylor College of Medicine | Mechanisms in Cancer Evolution | Susan Rosenberg, PhD; Joseph Petrosino, PhD |
Baylor College of Medicine | Nuclear Receptor, Transcription and Chromatin Biology | Suzanne Fuqua, PhD; Cheryl Walker, PhD |
Baylor College of Medicine | Pediatric Cancer Program | Susan Blaney, MD; Sharon Plon, MD, PhD |
University of Maryland | Experimental Therapeutics | Maria Baer, MD; Feyruz Rassool, PhD |
University of Maryland | Hormone Related Cancers | Stuart Martin, PhD; Arif Hussain, MD |
University of Maryland | Molecular and Structural Biology | David Weber, PhD; France Carrier, PhD |
University of Maryland | Population Science | Joanne Dorgan, MPH, PhD; Cheryl Knott, PhD, MA |
University of Maryland | Tumor Immunology and Immunotherapy | Xuefang Cao, PhD; Aaron Rapoport, MD |
Winship Cancer Institute of Emory University | Cancer Immunotherapy | Madhav Dhodapkar, MBBS; Rafi Ahmed, PhD |
Winship Cancer Institute of Emory University | Cancer Prevention and Control | Timothy Lash, DSc, MPH; Mylin Torres, MD |
Winship Cancer Institute of Emory University | Cell and Molecular Biology | Wei Zhou, PhD; Cheng-Kui Qu, MD, PhD |
Winship Cancer Institute of Emory University | Discovery and Developmental Therapeutics | Haian Fu, PhD; Kelly Goldsmith, MD |
Medical University of South Carolina | Cancer Biology and Immunology | Philip Howe, PhD; Sophie Paczesny, MD, PhD; Shikhar Mehrotra, PhD |
Medical University of South Carolina | Cancer Control | Matthew Carpenter, PhD; Ashish Deshmukh, PhD |
Medical University of South Carolina | Developmental Cancer Therapeutics | Nancy Klauber-DeMore, MD; John O'Bryan, PhD |
University of Texas Southwestern Medical Center | Cellular Networks in Cancer | Melanie Cobb, PhD; Ralph DeBarardinis, MD, PhD |
University of Texas Southwestern Medical Center | Chemistry and Cancer | Uttam Tambar, PhD; Daniel Siegwart, PhD |
University of Texas Southwestern Medical Center | Development and Cancer | Kathryn O'Donnell-Mendell, PhD; Hao Zhu, MD |
University of Texas Southwestern Medical Center | Experimental Therapeutics | John Minna, MD; Hans Hammers, MD, PhD |
University of Texas Southwestern Medical Center | Population Science and Cancer Control | Lindsay Cowell, PhD |
University of Kansas | Cancer Biology | Kristi Neufeld, PhD; Linheng Li, PhD; Sufi Thomas, PhD |
University of Kansas | Cancer Prevention and Control | Edward Ellerbeck, MD, MPH; Jennifer Klemp, PhD, MPH; Nikki Nollen, PhD |
University of Kansas | Drug Discovery, Delivery and Experimental Therapeutics | John Taylor, MD, MS; Dan Dixon, PhD; Priyanka Sharma, MD |
University of Kentucky | Cancer Prevention and Control | Krystle Kuhs, PhD; Jerod Stapleton, PhD |
University of Kentucky | Molecular and Cellular Oncology | Tianyan Gao, PhD; Rina Plattner, PhD; Binhua (Peter) Zhou, MD, PhD |
University of Kentucky | Translational Oncology | Susanne Arnold, MD; Jill Kolesar, PharmD |
Icahn School of Medicine at Mount Sinai | Cancer Clinical Investigation | Matthew Galsky, MD; Jian Jin, PhD; Samir Parekh, MBBS |
Icahn School of Medicine at Mount Sinai | Cancer Immunology | Nina Bhardwaj, MD, PhD; Miriam Merad, MD, PhD |
Icahn School of Medicine at Mount Sinai | Cancer Mechanisms | Emily Bernstein, PhD; Scott Friedman, MD |
Icahn School of Medicine at Mount Sinai | Cancer Prevention and Control | Jenny Lin, MD, MPH; Emanuela Taioli, MD, PhD |
University of Oklahoma Health Sciences Center | Cancer Biology | Min Li, PhD; Resham Bhattacharya, PhD |
University of Oklahoma Health Sciences Center | Cancer Prevention and Control | Darla Kendzor, PhD; CV Rao, PhD; Tim VanWagoner, PhD |
University of Oklahoma Health Sciences Center | Cancer Therapeutics | Kathleen Moore, MD, MS; Lacey McNally, PhD |
University of Miami Miller School of Medicine Cancer Center | Cancer Control | Frank Penedo, PhD; Tracy Crane, PhD, MS |
University of Miami Miller School of Medicine Cancer Center | Cancer Epigenetics | Ramin Shiekhattar, PhD; Maria Figueroa, MD; David Lombard, MD, PhD |
University of Miami Miller School of Medicine Cancer Center | Translational and Clinical Oncology | Carl Landgren, MD, PhD; Jaime Merchan, MD, MS |
University of Miami Miller School of Medicine Cancer Center | Tumor Biology | Wael El-Rifai, MD, PhD; Scott Welford, PhD; Priyamvada Rai, PhD |
Last Updated June 5, 2024